Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces Leadership Transition

See Release

All News

Archives

Endologix Announces Leadership Transition

Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session

Endologix Appoints Graham Phillips as Chief Operating Officer

One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)

Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit